RECURSION PHARMACEUTICALS, INC. (RXRX) Operating margin 2019–2025
RECURSION PHARMACEUTICALS, INC. (RXRX) operating margin by fiscal year — reported operating income divided by reported revenue.
-867.9%FY2025 · since FY2019: -2692.6% → -867.9%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -867.9% | -53.8 pp |
| FY2024 | -814.1% | -28.8 pp |
| FY2023 | -785.3% | -168.6 pp |
| FY2022 | -616.7% | +1179.0 pp |
| FY2021 | -1795.8% | +339.9 pp |
| FY2020 | -2135.7% | +556.9 pp |
| FY2019 | -2692.6% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice